Medpace Holdings Income After Taxes 2014-2024 | MEDP
- Medpace Holdings income after taxes for the quarter ending September 30, 2024 was $0.096B, a 36.68% increase year-over-year.
- Medpace Holdings income after taxes for the twelve months ending September 30, 2024 was $0.366B, a 33.85% increase year-over-year.
- Medpace Holdings annual income after taxes for 2023 was $0.283B, a 15.26% increase from 2022.
- Medpace Holdings annual income after taxes for 2022 was $0.245B, a 34.93% increase from 2021.
- Medpace Holdings annual income after taxes for 2021 was $0.182B, a 25.08% increase from 2020.
Medpace Holdings Annual Income After Taxes (Millions of US $) |
|
---|---|
2023 | $283 |
2022 | $245 |
2021 | $182 |
2020 | $145 |
2019 | $100 |
2018 | $73 |
2017 | $39 |
2016 | $13 |
2015 | $-9 |
2014 | $-16 |
2013 | $25 |
Medpace Holdings Quarterly Income After Taxes (Millions of US $) |
|
---|---|
2024-09-30 | $96 |
2024-06-30 | $88 |
2024-03-31 | $103 |
2023-12-31 | $78 |
2023-09-30 | $71 |
2023-06-30 | $61 |
2023-03-31 | $73 |
2022-12-31 | $69 |
2022-09-30 | $66 |
2022-06-30 | $49 |
2022-03-31 | $61 |
2021-12-31 | $50 |
2021-09-30 | $49 |
2021-06-30 | $40 |
2021-03-31 | $43 |
2020-12-31 | $51 |
2020-09-30 | $41 |
2020-06-30 | $24 |
2020-03-31 | $29 |
2019-12-31 | $30 |
2019-09-30 | $24 |
2019-06-30 | $27 |
2019-03-31 | $19 |
2018-12-31 | $23 |
2018-09-30 | $19 |
2018-06-30 | $17 |
2018-03-31 | $15 |
2017-12-31 | $11 |
2017-09-30 | $10 |
2017-06-30 | $10 |
2017-03-31 | $8 |
2016-12-31 | $-0 |
2016-09-30 | $5 |
2016-06-30 | $5 |
2016-03-31 | $3 |
2015-12-31 | |
2015-09-30 | $-0 |
2014-12-31 | |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $10.498B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.361B | 11.58 |
Cencora (COR) | United States | $48.280B | 17.81 |
DiDi Global (DIDIY) | China | $22.212B | 0.00 |
Natera (NTRA) | United States | $22.082B | 0.00 |
ICON (ICLR) | Ireland | $17.675B | 15.74 |
Viatris (VTRS) | United States | $15.958B | 4.92 |
Avantor (AVTR) | United States | $14.143B | 21.20 |
Revvity (RVTY) | United States | $13.634B | 23.68 |
CochLear (CHEOY) | Australia | $12.777B | 0.00 |
Solventum (SOLV) | United States | $12.233B | 0.00 |
BioMerieux (BMXMF) | France | $11.895B | 0.00 |
Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
HealthEquity (HQY) | United States | $9.104B | 49.41 |
Doximity (DOCS) | United States | $8.999B | 52.97 |
Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
Life Times (LTH) | United States | $5.081B | 33.63 |
Organon (OGN) | United States | $3.935B | 3.97 |
Sotera Health (SHC) | United States | $3.631B | 19.42 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
Concentras Parent (CON) | United States | $2.789B | 0.00 |
PACS (PACS) | United States | $2.515B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
Premier (PINC) | United States | $2.195B | 11.42 |
GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
Progyny (PGNY) | United States | $1.315B | 26.62 |
Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
CareDx (CDNA) | United States | $1.241B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
Embecta (EMBC) | United States | $0.797B | 5.32 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
Agilon Health (AGL) | United States | $0.779B | 0.00 |
SBC Medicals (SBC) | United States | $0.674B | 0.00 |
InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
DocGo (DCGO) | United States | $0.434B | 16.35 |
Enhabit (EHAB) | United States | $0.380B | 32.87 |
COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
ModivCare (MODV) | United States | $0.254B | 13.79 |
LifeMD (LFMD) | United States | $0.251B | 0.00 |
Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
Biodesix (BDSX) | United States | $0.186B | 0.00 |
Nutex Health (NUTX) | United States | $0.179B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
MultiPlan (MPLN) | United States | $0.112B | 0.00 |
So-Young (SY) | China | $0.086B | 16.60 |
Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.10 |
IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |